TY - GEN
T1 - Data Completion for Model Success Execution using Incremental MLP and LSTM Models
AU - Li, Yizhen
AU - Qin, Tao
AU - Zhu, Kuiyu
AU - Wang, Pinghui
N1 - Publisher Copyright:
© 2025 IEEE.
PY - 2025
Y1 - 2025
N2 - Almost all the models is the network today is running on different datasets, including the market analysis, demand forecasting, and healthcare policy development. However, missing or incomplete data, caused by factors such as data loss or market fluctuations, poses a significant challenge for downstream tasks. Traditional methods, like mean imputation, often fail to capture complex price variations. This paper proposes a drug price imputation method using Incremental MLP (IMLP) and LSTM models. We first clean the missing drug names and prices and apply normalization to handle price variations. Then, we use One-Hot Encoding to convert drug names into numerical vectors, forming the feature matrix, which is eventually input into the MLP and LSTM models. In addition, we introduce the IMLP model, which incorporates incremental learning to adapt to new drug types and price changes. Experimental results on four healthcare insurance drug price datasets show that IMLP outperforms LSTM, achieving an average R2 0.48 higher and 36.1% lower Mean Squared Error (MSE).
AB - Almost all the models is the network today is running on different datasets, including the market analysis, demand forecasting, and healthcare policy development. However, missing or incomplete data, caused by factors such as data loss or market fluctuations, poses a significant challenge for downstream tasks. Traditional methods, like mean imputation, often fail to capture complex price variations. This paper proposes a drug price imputation method using Incremental MLP (IMLP) and LSTM models. We first clean the missing drug names and prices and apply normalization to handle price variations. Then, we use One-Hot Encoding to convert drug names into numerical vectors, forming the feature matrix, which is eventually input into the MLP and LSTM models. In addition, we introduce the IMLP model, which incorporates incremental learning to adapt to new drug types and price changes. Experimental results on four healthcare insurance drug price datasets show that IMLP outperforms LSTM, achieving an average R2 0.48 higher and 36.1% lower Mean Squared Error (MSE).
KW - drug price imputation
KW - incremental learning
KW - medical data
KW - multi-layer perceptron
KW - price prediction
UR - https://www.scopus.com/pages/publications/105016123831
U2 - 10.1109/ES64449.2025.11136452
DO - 10.1109/ES64449.2025.11136452
M3 - 会议稿件
AN - SCOPUS:105016123831
T3 - 2025 8th International Conference on Enterprise Systems, ES 2025
BT - 2025 8th International Conference on Enterprise Systems, ES 2025
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 8th International Conference on Enterprise Systems, ES 2025
Y2 - 12 April 2025 through 13 April 2025
ER -